PeptiStar Inc.
Yamagata, Japan
Program data pending ClinicalTrials.gov matching
57.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: PeptiStar Inc.
- Signal Score
- 57.5/100
- Quality Compliance
- Assessment pending
- Headquarters
- Yamagata, Japan
- Modalities
- Peptide API, Oligonucleotide API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About PeptiStar Inc.
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesPeptide API, Oligonucleotide API
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
55.0
Manufacturing site information being gathered
Modalities: Peptide API, Oligonucleotide API
Capacity assessment: 55.0/100
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Manufacturing site information being gathered
Modalities: Peptide API, Oligonucleotide API
Capacity assessment: 55.0/100
Frequently Asked Questions About PeptiStar Inc.
What is PeptiStar Inc.'s CDMO Signal Score?
PeptiStar Inc. has a Signal Score of 58/100, based on quality, operations, financial stability, and capacity data.
Evaluating PeptiStar Inc. for a manufacturing program?
Use the free AI matchmaker to compare PeptiStar Inc. against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
AmbioPharm
North Augusta, SC
Peptide API, Peptide Vaccines, GMP Peptide Synthesis
CPC Scientific
Sunnyvale, CA
Peptide API, Oligonucleotide, GMP Peptide Synthesis
Laurus Labs
Hyderabad, India
Small Molecule API, Finished Dosage Form (FDF), CDMO (small molecule), Biologics / Large Molecule, Microbial Fermentation, Peptide API, Cell & Gene Therapy (early-stage investment), Anti-retroviral API, Oncology API, ADC (emerging)
Almac Group
Craigavon, United Kingdom
Peptide API, Small Molecule API, HPAPI, Drug Product (Oral, Injectable), Analytical Services
Dr. Reddy's Laboratories
Hyderabad, India
Small Molecule API, Generics, Biosimilars, Biologics (Drug Substance & Drug Product), Oligonucleotides, Steroids / Corticosteroids, Oncology / HPAPI, Sterile Injectables / Fill-Finish, Peptide API